<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35240927</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>14</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>16</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2164-554X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>18</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
              <Day>31</Day>
            </PubDate>
          </JournalIssue>
          <Title>Human vaccines &amp; immunotherapeutics</Title>
          <ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Longitudinally extensive transverse myelitis after Covid-19 vaccination: case report and review of literature.</ArticleTitle>
        <Pagination>
          <StartPage>2040239</StartPage>
          <MedlinePgn>2040239</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">2040239</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/21645515.2022.2040239</ELocationID>
        <Abstract>
          <AbstractText>Mass vaccination has been the main policy to overcome the Covid-19 pandemic. Several vaccines have been approved by the World Health Organization. With growing vaccination, safety concerns and adverse events that need prompt evaluation are also emerging. Herein, we report a case of a healthy woman with longitudinally extensive transverse myelitis after vaccination with the AstraZeneca vaccine. The patient was successfully treated after ruling out all the possible causes.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Maroufi</LastName>
            <ForeName>Seyed Farzad</ForeName>
            <Initials>SF</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Naderi Behdani</LastName>
            <ForeName>Fereshteh</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Ziaeian Hospital, Tehran University of Medical Science, Tehran, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rezania</LastName>
            <ForeName>Fatemeh</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Neurosciences Department, St Vincent's Hospital, Melbourne, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tanhapour Khotbehsara</LastName>
            <ForeName>Samaneh</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mirzaasgari</LastName>
            <ForeName>Zahra</ForeName>
            <Initials>Z</Initials>
            <Identifier Source="ORCID">0000-0002-4046-8471</Identifier>
            <AffiliationInfo>
              <Affiliation>Neurology Department, Firoozgar Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>03</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Hum Vaccin Immunother</MedlineTA>
        <NlmUniqueID>101572652</NlmUniqueID>
        <ISSNLinking>2164-5515</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014612">Vaccines</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009188" MajorTopicYN="Y">Myelitis, Transverse</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014612" MajorTopicYN="Y">Vaccines</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">AstraZeneca</Keyword>
        <Keyword MajorTopicYN="Y">Covid-19</Keyword>
        <Keyword MajorTopicYN="Y">Transverse myelitis</Keyword>
      </KeywordList>
      <CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>4</Day>
          <Hour>5</Hour>
          <Minute>32</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35240927</ArticleId>
        <ArticleId IdType="pmc">PMC9009891</ArticleId>
        <ArticleId IdType="doi">10.1080/21645515.2022.2040239</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Ahmad I, Rathore FA.. 
Neurological manifestations and complications of COVID-19: a literature review. J Clin Neurosci. 2020;77:8–4. doi:10.1016/j.jocn.2020.05.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jocn.2020.05.017</ArticleId>
            <ArticleId IdType="pmc">PMC7200361</ArticleId>
            <ArticleId IdType="pubmed">32409215</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heinz FX, Stiasny K. Profiles of current COVID-19 vaccines. Wien Klin Wochenschr. 2021;133(7–8):271–83. doi:10.1007/s00508-021-01835-w.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00508-021-01835-w</ArticleId>
            <ArticleId IdType="pmc">PMC7962631</ArticleId>
            <ArticleId IdType="pubmed">33725201</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ozonoff A, Nanishi E, Levy O. Bellʻs palsy and SARS-CoV-2 vaccines. Lancet Infect Dis. 2021;21(4):450–52. doi:10.1016/s1473-3099(21)00076-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s1473-3099(21)00076-1</ArticleId>
            <ArticleId IdType="pmc">PMC7906673</ArticleId>
            <ArticleId IdType="pubmed">33639103</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cirillo N, Doan R. Bellʻs palsy and SARS-CoV-2 vaccines-an unfolding story. Lancet Infect Dis. 2021;21(9):1210–11. doi:10.1016/s1473-3099(21)00273-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s1473-3099(21)00273-5</ArticleId>
            <ArticleId IdType="pmc">PMC8184125</ArticleId>
            <ArticleId IdType="pubmed">34111409</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Colella G, Orlandi M, Cirillo N. Bellʻs palsy following COVID-19 vaccination. J Neurol. 2021;21:1–3. doi:10.1007/s00415-021-10462-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00415-021-10462-4</ArticleId>
            <ArticleId IdType="pmc">PMC7897359</ArticleId>
            <ArticleId IdType="pubmed">33611630</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Márquez Loza AM, Holroyd KB, Johnson SA, Pilgrim DM, Amato AA. Guillain-Barré syndrome in the placebo and active arms of a COVID-19 vaccine clinical trial: temporal associations do not imply causality article-title. Neurology. 2021;96(22):1052–54. doi:10.1212/wnl.0000000000011881.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/wnl.0000000000011881</ArticleId>
            <ArticleId IdType="pubmed">33824169</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Waheed S, Bayas A, Hindi F, Rizvi Z, Espinosa PS. Neurological complications of COVID-19: Guillain-Barre syndrome following Pfizer COVID-19 vaccine. Cureus. 13(2), e13426. DOI: 10.7759/cureus.13426.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7759/cureus.13426</ArticleId>
            <ArticleId IdType="pmc">PMC7978140</ArticleId>
            <ArticleId IdType="pubmed">33758714</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bourdette D, Killestein J. Quelling public fears About Guillain-Barré syndrome and COVID-19 vaccination. Neurology. 2021;96(22):1021–22. doi:10.1212/wnl.0000000000011882.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/wnl.0000000000011882</ArticleId>
            <ArticleId IdType="pubmed">33824170</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Román GC, Gracia F, Torres A, Palacios A, Gracia K, Harris D. Acute Transverse Myelitis (Atm):clinical review of 43 patients with COVID-19-associated ATM and 3 post-vaccination ATM serious adverse events with the ChAdox1 nCov-19 vaccine (AZD1222). Front Immunol. 2021;12:653786. doi:10.3389/fimmu.2021.653786.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2021.653786</ArticleId>
            <ArticleId IdType="pmc">PMC8107358</ArticleId>
            <ArticleId IdType="pubmed">33981305</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krishnan C, Kaplin AI, Deshpande DM, Pardo CA, and Kerr DA. Transverse Myelitis: pathogenesis, diagnosis and treatment. Frontiers in Bioscience: A Journal and Virtual Library. 2004. 
May
1;9(2):1483–99.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14977560</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tahir N, Koorapati G, Prasad S et al. SARS-CoV-2 vaccination-induced transverse myelitis. Cureus. 2021;13(7):e16624.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8384391</ArticleId>
            <ArticleId IdType="pubmed">34458035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Erdem N, Demirci S, Özel T, Mamadova K, Karaali K, Çelik HT, Uslu FI, Özkaynak SS et al. Acute transverse myelitis after inactivated COVID-19 vaccine. Ideggyógyászati Szemle. 747–8:273–76. Akut transversalis myelitis inaktivált vírust alkalmazó Covid-19-vakcináció után. doi:10.18071/isz.74.0273.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18071/isz.74.0273</ArticleId>
            <ArticleId IdType="pubmed">34370410</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pagenkopf C, Südmeyer M. A case of longitudinally extensive transverse myelitis following vaccination against Covid-19. J Neuroimmunol. ;358:577606. doi:10.1016/j.jneuroim.2021.577606.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jneuroim.2021.577606</ArticleId>
            <ArticleId IdType="pmc">PMC8223023</ArticleId>
            <ArticleId IdType="pubmed">34182207</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alabkal J, Rebchuk A, Lyndon D, Randhawa N. Incomplete subacute transverse myelitis following vaccination with Pfizer-BioNtech COVID-19 mRNA vaccine: a case report. Cureus. 2021.  ;12. doi:10.7759/cureus.20460.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7759/cureus.20460</ArticleId>
            <ArticleId IdType="pmc">PMC8760850</ArticleId>
            <ArticleId IdType="pubmed">35070526</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gao J-J, Tseng H-P, Lin C-L, Shiu J-S, Lee M-H, Liu C-H. Acute transverse myelitis following COVID-19 vaccination. Vaccines. 2021;9(9). doi:10.3390/vaccines9091008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/vaccines9091008</ArticleId>
            <ArticleId IdType="pmc">PMC8470728</ArticleId>
            <ArticleId IdType="pubmed">34579245</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sakakibara R, Hattori T, Yasuda K, Yamanishi T. Micturition disturbance in acute transverse myelitis. Spinal Cord. 1996. 
August
1;34(8):481–85. doi:10.1038/sc.1996.82.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sc.1996.82</ArticleId>
            <ArticleId IdType="pubmed">8856855</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khan E, Shrestha AK, Colantonio MA, Liberio RN, Sriwastava S. Acute transverse myelitis following SARS-CoV-2 vaccination: a case report and review of literature. J Neurol. 2021;5:1–12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8418691</ArticleId>
            <ArticleId IdType="pubmed">34482455</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shoenfeld Y, Aron-Maor A. Vaccination and autoimmunity—‘vaccinosisʻ: a dangerous liaison?
J Autoimmun. 2000. 
February
1;14(1):1–10. doi:10.1006/jaut.1999.0346.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1006/jaut.1999.0346</ArticleId>
            <ArticleId IdType="pubmed">10648110</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Transverse Myelitis Consortium Working Group* . Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology. 2002;59(4):499–505. doi:10.1212/WNL.59.4.499.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.59.4.499</ArticleId>
            <ArticleId IdType="pubmed">12236201</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goss AL, Samudralwar RD, Das RR, Nath A. ANA investigates: neurological complications of COVID-19 vaccines. Ann Neurol. 2021. 
May
1;89(5):856–57. doi:10.1002/ana.26065.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ana.26065</ArticleId>
            <ArticleId IdType="pmc">PMC8250888</ArticleId>
            <ArticleId IdType="pubmed">33710649</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Knoll MD, Wonodi C. Oxford–astrazeneca COVID-19 vaccine efficacy. Lancet. 2021;397(10269):72–74. doi:10.1016/S0140-6736(20)32623-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(20)32623-4</ArticleId>
            <ArticleId IdType="pmc">PMC7832220</ArticleId>
            <ArticleId IdType="pubmed">33306990</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, et al. Safety and efficacy of the ChAdox1 nCov-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397(10269):99–111. doi:10.1016/S0140-6736(20)32661-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(20)32661-1</ArticleId>
            <ArticleId IdType="pmc">PMC7723445</ArticleId>
            <ArticleId IdType="pubmed">33306989</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singh Malhotra H, Gupta P, Prabhu V, Kumar Garg R, Dandu H, Agarwal V. COVID-19 vaccination-associated myelitis. Qjm. 2021;114(8):591–93. doi:10.1093/qjmed/hcab069.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/qjmed/hcab069</ArticleId>
            <ArticleId IdType="pmc">PMC8083508</ArticleId>
            <ArticleId IdType="pubmed">33787891</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
